World's Best Scientists 2026 revealed!
Ellen L. Goode

Ellen L. Goode

D-Index & Metrics

Biology and Biochemistry

D-Index
88
Citations
31225
World Ranking
2676
National Ranking
1391

Overview

Ellen L. Goode is affiliated with the Mayo Clinic in the United States and has a significant body of research focused on oncology, genetics, and molecular biology. Their work spans multiple disciplines within medicine, with a primary focus on cancer-related studies.

The main fields of study for Ellen L. Goode include Medicine and Biochemistry, Genetics and Molecular Biology. More specifically, their subfields of study cover Reproductive Medicine, Molecular Biology, Genetics, Cancer Research, and Oncology.

The scientist's research topics are centered on:

  • Ovarian cancer diagnosis and treatment
  • Cancer-related molecular mechanisms research
  • BRCA gene mutations in cancer
  • Endometrial and Cervical Cancer Treatments
  • Genetic Associations and Epidemiology
  • Genetic factors in colorectal cancer
  • RNA modifications and cancer

Ellen L. Goode has contributed to a range of scientific publications, frequently collaborating with other researchers. Their frequent co-authors include Susan J. Ramus, Paul D.P. Pharoah, Anna deFazio, David D.L. Bowtell, and Stacey J. Winham.

The scientist's research has appeared repeatedly in several publication venues, which include:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Clinical Cancer Research
  • Gynecologic Oncology

Some of Ellen L. Goode's recent papers cover a variety of topics related to cancer genomics and risk prediction. Notable papers include:

  • Prognostic gene expression signature for high-grade serous ovarian cancer, 2020, Annals of Oncology
  • Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers, 2020, Nature Communications
  • The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer, 2022, Nature Genetics
  • Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes, 2022, Clinical Cancer Research
  • Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors, 2022, Circulation

Best Publications

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.

    Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee

  • Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

    Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson

  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

    Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki

  • A common coding variant in CASP8 is associated with breast cancer risk

    Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

    Shahana Ahmed;Gilles Thomas;Maya Ghoussaini;Catherine S. Healey

  • Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

    Montserrat Garcia-Closas;Per Hall;Heli Nevanlinna;Karen Pooley

  • Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    Weiva Sieh;Martin Köbel;Teri A Longacre;David D Bowtell;David D Bowtell

  • Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

    Susan J. Ramus;Honglin Song;Ed Dicks;Jonathan P. Tyrer

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan

  • Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36

    Mark Gibbs;Janet L. Stanford;Richard A. McIndoe;Gail P. Jarvik

  • A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

    Ellen L Goode;Georgia Chenevix-Trench;Honglin Song;Susan J Ramus

  • Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

    Gottfried E. Konecny;Chen Wang;Habib Hamidi;Boris Winterhoff

  • Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

    Honglin Song;Ed Dicks;Susan J. Ramus;Jonathan P. Tyrer

  • Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

    Xin Yang;Goska Leslie;Alicja Doroszuk;Sandra Schneider

  • A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

    Honglin Song;Susan J. Ramus;Jonathan Tyrer;Kelly L. Bolton;Kelly L. Bolton

  • Age-Related Lobular Involution and Risk of Breast Cancer

    Tia R. Milanese;Lynn C. Hartmann;Thomas A. Sellers;Marlene H. Frost

Frequent Co-Authors

Susan J. Ramus
Susan J. Ramus University of New South Wales
Brooke L. Fridley
Brooke L. Fridley University of Kansas
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge
Joellen M. Schildkraut
Joellen M. Schildkraut University of Virginia
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Andrew Berchuck
Andrew Berchuck Duke University
Graham G. Giles
Graham G. Giles University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ellen L. Goode

Trending Scientists